Medicare Enrolled

Dr. Jack Berger, MD

Rheumatology · Purchase, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
3030 WESTCHESTER AVE, Purchase, NY 10577
9146826511
In practice since 2005 (20 years)
NPI: 1770568719 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Berger from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Berger? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Berger

Dr. Jack Berger is a rheumatology specialist in Purchase, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Berger performed 29,700 Medicare services across 884 unique beneficiaries.

Between the years covered by Open Payments, Dr. Berger received a total of $2,069 from 11 pharmaceutical and/or device companies across 28 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Berger is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 11% volume in NY $2,069 industry payments

Medicare Practice Summary

Medicare Utilization ↗
29,700
Medicare services
Top 11% in NY for rheumatology
884
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,485 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Certolizumab injection (Cimzia)
An injection of certolizumab pegol administered under the direct supervision of a physician.
15,200 $4 $20
Tocilizumab injection (Actemra) 11,040 $5 $11
Denosumab injection (Prolia/Xgeva) 2,460 $17 $43
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
157 $8 $9
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
141 $83 $332
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
87 $10 $58
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
85 $9 $88
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
75 $6 $206
Erythrocyte sedimentation rate (ESR) test
A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine.
73 $4 $17
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
72 $8 $29
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
71 $106 $944
C-reactive protein test (inflammation marker)
A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body.
55 $5 $25
Vitamin D level test
A blood test to measure the amount of Vitamin D-3 in your body.
40 $29 $200
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
31 $27 $141
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
31 $60 $227
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
18 $38 $313
Thyroid stimulating hormone (TSH) test
A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function.
15 $16 $75
Rheumatoid factor level 15 $6 $54
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
12 $143 $446
Basic metabolic blood panel
A blood test that measures a group of basic chemicals, including total calcium levels.
11 $8 $40
Lipid panel (cholesterol and triglycerides)
A blood test that measures cholesterol and triglyceride levels.
11 $13 $82
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
97.3% medium
2.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$2,069
Total received (2018-2024)
Avg $296/year across 7 years
Bottom 49% in NY for rheumatology
11
Companies
28
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,069 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$116
2023
$222
2022
$463
2021
$147
2020
$125
2019
$496
2018
$500

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ANI Pharmaceuticals, Inc.
$116
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$378
PFIZER INC.
$375
Novartis Pharmaceuticals Corporation
$343
UCB, Inc.
$250
AbbVie Inc.
$125
ABBVIE INC.
$125
AstraZeneca Pharmaceuticals LP
$125
Mallinckrodt Hospital Products Inc.
$123
ANI Pharmaceuticals, Inc.
$116
Lilly USA, LLC
$88
NOVARTIS PHARMACEUTICALS CORPORATION
$22
Top 3 companies account for 53.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · COSENTYX · Cimzia · EVENITY · Enbrel · PURIFIED CORTROPHIN GEL · RINVOQ · SAPHNELO · TALTZ · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology specialist in Purchase?
Compare rheumatologists in the Purchase area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
276
Per 100K population
27.7
County median income
$118,411
Nearest hospital
WHITE PLAINS HOSPITAL CENTER
2.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Berger is a mixed practice specialist, with above-average Medicare volume (top 11% in NY), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Berger experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Berger performed 15,200 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Berger receive payments from pharmaceutical companies?
Yes. Dr. Berger received a total of $2,069 from 11 companies across 28 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Berger's costs compare to other rheumatologists in Purchase?
Dr. Berger's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Berger) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →